Inhibiting NR4A1, NR4A2 and N4RA3 in CAR Ts to enhance efficacy in solid tumors

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; colorectal cancer

Mouse studies suggest inhibiting NR4A1, NR4A2 and NR4A3 in CAR T cells could

Read the full 196 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE